Table 3.
Literature review of delayed presentations of STEMI with complications during COVID-19 pandemic
Author | Country | Publication month/year | Age/sex | Comorbidities | Clinical presentation | COVID-19 status | ECG/ cardiac enzymes | Multimodality imaging | Invasive findings | Management | Clinical course | Outcome |
Moroni et al2 | Italy | March/2020 | 64/M | Not reported | Left lower limb pain, cyanosis and paraesthesia for 10 days. CP and SOB for 10 days | NR | Q waves and STE in inferior leads | TTE: severe LV dilation, systolic dysfunction and apical thrombus. CTA: LAD occlusion, thromboembolic material in femoral arteries | Not performed | Emergent amputation of left lower limb | Cardiogenic shock necessitating inotropes and IABP | Recovered and discharged from ICU |
Moroni et al2 | Italy | March/2020 | 65/F | Not reported | Progressive SOB for 5 days, hypotension and respiratory distress. Episode of epigastric tightness few days earlier treated with antacids at home | NR | Q waves and STE anterior leads | CXR: acute pulmonary oedema. TTE: severe LV dysfunction, apical aneurysm, anteroseptal and anteroapical dyskinesia. CTA: critical LAD stenosis | Not performed | Intravenous diuretics, inotropic support and non-invasive ventilation | Not significant | Transferred to cardiology ward |
Moroni et al2 | Italy | March/2020 | 60/M | Not reported | Hypotension, diaphoresis, respiratory distress. Four-day history of crushing chest pain | NR | STE and Q waves in anterior leads | TTE: severe LV dysfunction with anteroseptal, anteroapical and lateral akinesia | LHC: CTO of proximal RCA and acute occlusion of proximal LAD | LHC: no-reflow phenomenon after stent implantation to LAD and ventricular fibrillation requiring defibrillation with I&V | ROSC, cardiogenic shock necessitating inotropes and mechanical support with Imeplla CP | Died after few days |
Gadella et al19 | Spain | April/2020 | 65/F | Dyslipidaemia, chronic hepatitis C, cervical cancer with surgical removal and active smoking | Typical CP for 24 hours, low grade fever and dry cough, and tachypnoea | + | Acute evolving anterior MI | CXR: bilateral patchy infiltrates. TTE: extensive LV wall motion abnormalities and severe systolic dysfunction | Urgent angiography and PCI deferred and considered elective after recovery from COVID-19 | Aspirin, ticagrelor, empiric ceftriaxone and azithromycin, and hydroxychloroquine | Cardiogenic shock in 24 hours. New-onset holosystolic murmur and 13 mm apical VSR. | Patient managed conservatively and died the following day |
Ullah et al20 | USA | May/2020 | 36/M | No comorbidities | Unresponsive at home and last seen normal 15 hours ago | + | STE V2–V4. TnT elevated | TTE: extensive septal, anterior and apical akinesia with apical LV thrombus and EF of 35% (normal >55%). CXR and CT of the chest: multifocal infiltrates | LHC: 99% occlusion of LAD | DES in LAD, aspirin, clopidogrel, atorvastatin, carvedilol and lisinopril | Refused further work-up and discharged home | Not reported |
Dash et al21 | India | June/2020 | 59/F | HTN, DM, CAD with STEMI in March 2020 | Dyspnoea for 2 days, tachycardia and hypoxia | NR | Left-axis deviation with Qs in anterior leads; TnT positive | Not reported | Not performed | Non-invasive ventilation, inotrope infusions, heparin, antiplatelets, lipid-lowering agents, antianginals and antibiotics | Gradual oliguria followed by anuria with severe metabolic acidosis and refractory hypotension | Cardiac arrest and died |
Dash et al21 | India | June/2020 | 58/F | DM and HTN | Anginal chest pain, dyspnoea and autonomic symptoms | NR | Qs complex in V1–V4. TnT + | CXR: cardiomegaly with bilateral alveolar opacities | Not performed | Oxygen, heparin, diuretics, antiplatelets, insulin and lipid-lowering agents | Responded well with symptom relief | Discharged from hospital |
Dash et al21 | India | June/2020 | 69/M | Not reported | Chest pain for more than 12 hours | NR | STE I, aVL with reciprocal ST depressions | Not performed | Ostial LAD 100% occlusion with poor retrograde filling from RCA | Repeated thrombosuction of LAD and DES to LAD | Managed on antiplatelets and inotropes, and developed refractory pulmonary oedema requiring I&V | Died after 12 hours |
Mitevska et al22 | North Macedonia | May/2020 | 47/M | HTN, DM II, smoking and increased body weight | Recurrent episodes of CP for 2 days prior to hospitalisation | – | Sinus tachycardia with STE in leads V2–V6, I, II, III and aVF. HsTnt 6385 ng/mL (normal <15 ng/mL) | TTE: akinesia of apex, anterior wall, mid-apical septal wall and global reduction in LV function with EF 35% | LHC: 99% stenosis of mid LAD, CTO of LCx and OM1, and 95% stenosis of RCA | DES to culprit lesion in mid LAD followed by another stage procedure with DES to proximal RCA on day 3 of hospitalisation | Angina relieved and STE resolution | Discharged on day 7 of hospitalisation and clinically stable |
El Sakr and Marshall23 | USA | June/2020 | 64/F | 40-pack year history of tobacco use and mild COPD | CP and SOB for 1 day. Muscle and back aches for 5 days | – | STE in II, III, aVF, V3–V6 with reciprocal changes in I and aVL | TTE: inferior, inferoseptal, inferolateral and proximal-mid anteroseptal wall hypokinesis | LHC: occluded mid PCA, LVEDP 34 mm Hg (normal 19 mm Hg) and VSD. RHC: 73% sat on RV c/w step up and shunt, PCWP of 26 mm Hg (normal 12 mm Hg) | IABP support, rotational atherectomy and DES to RCA. Cardiac CT: VSD in basilar inferior septum with patch repair on day 4, mechanical support escalated to ECMO and Impella for cardiogenic shock | Postoperative bleeding requiring reoperation | Died |
Joshi et al24 | USA | June/2020 | 72/F | Dyslipidaemia and CAD with PCI in 2002 | Substernal chest heaviness, light headedness and patient presentation 14 hours after persistent symptoms | NR | STE in inferior leads with Q waves reciprocal ST depressions and elevated TnT | CTA: insignificant |
LHC: occlusion of mid RCA and ventriculogram showed VSR. RHC: O2 step up in RV and Qp:Qs 2.2:1 | DES to mid RCA | Patient wished comfort measures | Died |
Alsidawi et al25 | USA | June/2020 | 67/F | CAD with prior LCx stent | CP, delayed seeking medical attention and presented after 14 hours | NR | Inferior STE with Q wave and elevated Tnt | TTE: EF 50% and hypokinesis of inferior and inferoseptal myocardium | LHC: dominant RCA totally occluded | Aspiration thrombectomy with symptom resolution | Discharged and presented with shock and new murmur 5 days later and found to have VSR | Complex VSD repair and ICU admission |
Alsidawi et al25 | USA | June/2020 | 62/F | HTN and MS | Chest pain for 4 days, dyspnoea and fever. Systolic thrill on examination | – | Anterior STE with Q waves | TTE: EF 35% with LAD WMA, apical VSR | RHC:Qp:Qs 1.5:1 | Patient elected non-invasive management | Transitioned to hospice care | Not reported |
Otero et al26 | USA | July/2020 | 69/M | HTN, HD, DM II, tobacco use and aortic aneurysm | Exertional chest pain of unknown duration | – | Posterior STE | TTE: EF 25% and small circumferential pericardial effusion with visible thrombus | LHC: 100% occlusion of LCx and 90% occlusion of LAD. Unable to wore or balloon due to extensive thrombus burden | Initially received tenecteplase, aspirin and clopidogrel | Transferred to ICU on IABP. Medical management of STEMI. Avoidance of anticoagulation due to haemorrhagic pericardial effusion due to tenecteplase | Repeat TTE with resolution of pericardial effusion, staged PCI of LAD and discharged on day 19 |
The present report of patient 1 | USA | 2020 | 62/F | Cigarette smoking, hyperlipidaemia and obesity | Nausea, diarrhoea and chest pain for 2 weeks. SOB for 1 day. | – | Wide complex tachycardia. Elevated hsTnt and Tnt | TTE: severely reduced biventricular function | RHC: cardiogenic shock. LHC: total occlusion of RCA and 90% stenosis of LAD | Asystole during PCI and worsening cardiogenic shock with VA-ECMO support | Successful decannulation from VA-ECMO on day 7 and repeat TTE: LVEF 50% | Recovering on medical floor |
The present report of patient 2 | USA | 2020 | 82/F | CAD, vascular disease, HTN, hyperlipidaemia and smoker | SOB and leg swelling for 2 days. New systolic murmur | – | STE V2–V6 with Q waves. Tnt elevated | TTE: LVEF 30% and muscular VSR | RHC: O2 step up in RV, Qp:Qs: 1:56. LHC: total occlusion of LAD, stenosis in LCx, RCA and muscular VSR | Antiplatelets, statin and anticoagulation | Progressive SOB on discharge and underwent percutaneous closure of VSR | Recovering well on medical floor |
CAD, coronary artery disease; CP, chest pain; CXR, chest X-ray; DM, diabetes mellitus; EF, ejection fraction; HTN, hypertension; IABP, intra-aortic balloon pump; ICU, intensive care unit; I&V, intubation and ventilation; LAD, left anterior descending artery; LHC, left heart catheterisation; LV, left ventricle; PCI, percutaneous coronary intervention; RCA, right coronary artery; RHC, right heart catheterization; ROSC, return of spontaneous circulation; SOB, shortness of breath; STE, ST-segment elevations; STEMI, ST-segment elevation myocardial infarction; TnT, troponin T; TTE, transthoracic echocardiogram; VA-ECMO, venoarterial extracorporeal membrane oxygenation; VSD/R, ventricular septal defect/rupture.